Search

Search Constraints

You searched for: Author/Creator Tapaninen, Tuija

Search Results

1. A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics. Issue 1 (22nd August 2022)

2. Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics. Issue 1 (6th November 2017)

3. Effect of High‐Dose Esomeprazole on CYP1A2, CYP2C19, and CYP3A4 Activities in Humans: Evidence for Substantial and Long‐lasting Inhibition of CYP2C19. Issue 6 (2nd August 2020)

4. Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects. Issue 3 (17th November 2017)

6. Genomewide Association Study of Simvastatin Pharmacokinetics. Issue 3 (24th June 2022)

7. Identification of novel genetic variants associated with membrane transporter, drug metabolizing enzyme and nuclear receptor gene expression in whole blood. Issue 1 (January 2017)

8. Itraconazole Increases Ibrutinib Exposure 10‐Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug‐Drug Interaction. Issue 2 (29th November 2019)

9. Pharmacogenomics of celiprolol – evidence for a role of P‐glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics. Issue 2 (29th September 2021)

10. UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics—A Comprehensive Pharmacogenomic Study. Issue 4 (10th July 2020)